پديد آورندگان :
Konstantinos Papadopoulos I. نويسنده , Goran Sundkvist نويسنده , Henrik Borg نويسنده , Bengt Hallengren نويسنده
چكيده لاتين :
T he existence of an association between
glutamic acid decarboxylase 65 antibodies
(GADA) and/or IA2 antibodies
and sarcoidosis was evaluated.
Materials and Methods: 78 patients with documented
sarcoidosis, divided according to the
presence (N=37) or absence (N=41) of autoimmune
manifestations were evaluated for GADA
and IA2 antibodies using, a radioligand assay
with human recombinant 35S-labeled GAD65
and IA2 respectively.
Results: Two patients with GADA (2.6%) and
one (1.3%) with IA2ab, both in the group of patients
with autoimmunity associated sarcoidosis
were found. The GADA positive patient had
manifest Type 1 diabetes that succeeded sarcoidosis.
IA2 ab-positivity was seen among patients
with isolated sarcoidosis. GADA and IA2ab frequencies
were not increased compared to reference
subjects (2-3%).
Conclusions: No clear association between sarcoidosis
and GADA and/or IA2ab was found. In
patients with sarcoidosis, GADA seem to be associated
with type 1 diabetes or other autoimmune
manifestations rather than with sarcoidosis
per se.